This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Pain Detection and Interception in Neonates

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified March 2007 by Sorlandet Hospital HF.
Recruitment status was:  Recruiting
Helse sor
Information provided by:
Sorlandet Hospital HF Identifier:
First received: March 13, 2007
Last updated: NA
Last verified: March 2007
History: No changes posted


  1. May the introduction of NIDCAP during blood sample reduced pain in neonates during blood sample
  2. Compare the effect of venous and capillary blood sample method

Condition Intervention
Pain Detection Pain Intervention Procedure: Introduction of better conditions during blood sampling

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind
Primary Purpose: Treatment
Official Title: Pain Detection and Interception in Neonates During Blood Sampling

Further study details as provided by Sorlandet Hospital HF:

Primary Outcome Measures:
  • value of Premature Infant Pain Profile
  • Heart rate
  • Saturation
  • Skin conductance changes

Estimated Enrollment: 160
Study Start Date: March 2007
Estimated Study Completion Date: November 2009
Detailed Description:
introducing the: Newborn Individualized Developmental Care and Assessment Program

Ages Eligible for Study:   31 Weeks to 36 Weeks   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Born gestation age 31-36

Exclusion Criteria:

  • Infection, respiratory distress
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00447824

Contact: Knut G Hernes, Dr +(47) 957 99999

Sorlandet Hospital SSHF Recruiting
Kristiansand, Vest Agder, Norway, 4600
Sub-Investigator: Liv Normann         
Sub-Investigator: Randi S Dahl         
Sponsors and Collaborators
Sorlandet Hospital HF
Helse sor
Study Chair: Knut G Hernes, Dr
  More Information Identifier: NCT00447824     History of Changes
Other Study ID Numbers: S-06471a
Study First Received: March 13, 2007
Last Updated: March 13, 2007

Keywords provided by Sorlandet Hospital HF:
Capillary processed this record on June 22, 2017